| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
5,524,000 |
| Market
Cap: |
638.02(M) |
| Last
Volume: |
33,304 |
Avg
Vol: |
40,495 |
| 52
Week Range: |
$84.55 - $167.46 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
| Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
| Total People Sold |
0 |
1 |
3 |
8 |
| Total Sell Transactions |
0 |
1 |
5 |
25 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sakys John V |
CFO |
• – – |
2021-10-20 |
4 |
AS |
$309.86 |
$619,720 |
D/D |
(2,000) |
7,514 |
|
-17% |
|
| Sakys John V |
CFO |
• – – |
2021-10-20 |
4 |
OE |
$97.78 |
$195,560 |
D/D |
2,000 |
9,514 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-10-01 |
4 |
AS |
$304.48 |
$380,600 |
D/D |
(1,250) |
21,857 |
|
-14% |
|
| Sakys John V |
CFO |
• – – |
2021-09-10 |
4 |
AS |
$270.21 |
$378,294 |
D/D |
(1,400) |
7,514 |
|
10% |
|
| Sakys John V |
CFO |
• – – |
2021-09-10 |
4 |
OE |
$89.70 |
$125,580 |
D/D |
1,400 |
8,914 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-09-01 |
4 |
AS |
$268.22 |
$335,275 |
D/D |
(1,250) |
23,107 |
|
11% |
|
| Kelly David M |
Director |
– • – |
2021-08-31 |
4 |
S |
$267.29 |
$161,176 |
D/D |
(603) |
2,600 |
|
-13% |
|
| Sullivan John James |
Director |
– • – |
2021-08-18 |
4 |
OE |
$70.56 |
$70,560 |
D/D |
1,000 |
24,357 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-08-16 |
4 |
S |
$272.16 |
$1,413,055 |
D/D |
(5,192) |
23,357 |
|
-24% |
|
| Sullivan John James |
Director |
– • – |
2021-08-16 |
4 |
OE |
$89.70 |
$465,722 |
D/D |
5,192 |
28,549 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
23,357 |
|
- |
|
| Hall Shannon |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
756 |
|
- |
|
| Alltoft Jennifer Sadie |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
1,215 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
29,758 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
71,015 |
|
- |
|
| Kelly David M |
Director |
– • – |
2021-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
308 |
3,203 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-08-12 |
4 |
AS |
$275.16 |
$275,160 |
D/D |
(1,000) |
7,514 |
|
18% |
|
| Sakys John V |
CFO |
• – – |
2021-08-12 |
4 |
OE |
$89.70 |
$89,700 |
D/D |
1,000 |
8,514 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2021-08-11 |
4 |
AS |
$278.06 |
$222,448 |
D/D |
(800) |
70,707 |
|
17% |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2021-08-09 |
4 |
S |
$280.03 |
$178,939 |
D/D |
(639) |
154 |
|
-14% |
|
| Sullivan John James |
Director |
– • – |
2021-08-02 |
4 |
AS |
$290.47 |
$363,088 |
D/D |
(1,250) |
23,049 |
|
12% |
|
| Guillemin Evan |
Director |
– • – |
2021-07-16 |
4 |
AS |
$282.18 |
$203,170 |
D/D |
(720) |
29,450 |
|
10% |
|
| Sakys John V |
CFO |
• – – |
2021-07-12 |
4 |
AS |
$278.77 |
$278,770 |
D/D |
(1,000) |
7,514 |
|
9% |
|
| Sakys John V |
CFO |
• – – |
2021-07-12 |
4 |
OE |
$89.70 |
$89,700 |
D/D |
1,000 |
8,514 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-07-01 |
4 |
S |
$267.04 |
$267,040 |
D/D |
(1,000) |
7,514 |
|
-20% |
|
453 Records found
|
|
Page 6 of 19 |
|
|
2.13 (1.88%) 
